Premium
Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease
Author(s) -
Pittman Jessica E.,
Calloway Elizabeth H.,
Kiser Michelle,
Yeatts John,
Davis Stephanie D.,
Drumm Mitchell L.,
Schechter Michael S.,
Leigh Margaret W.,
Emond Mary,
Van Rie Annelies,
Knowles Michael R.
Publication year - 2011
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.21397
Subject(s) - medicine , cystic fibrosis , odds ratio , lung , respiratory disease , gastroenterology , quartile , cohort , pneumonia , confidence interval
Rationale Pseudomonas aeruginosa ( Pa ) is associated with poor pulmonary outcomes in cystic fibrosis (CF), but the association between age of Pa infection and severity of subsequent lung disease has not been thoroughly investigated. Objective Our goal was to determine the association between age of Pa acquisition and subsequent severity of CF lung disease. Methods Case–control study using CF Foundation Registry data of 629 ΔF508 homozygotes with severe and mild lung disease (FEV 1 in the lowest and highest quartile of birth cohort, respectively). Multivariate logistic regression was performed to determine the association between age of Pa acquisition and lung disease severity. Results Earlier age of Pa infection was strongly associated with increased odds of severe lung disease. For first and persistent Pa , adjusted odds ratios for severe lung disease were 6.5 (95% CI 3.1, 13.7; P < 0.0001) and 11.2 (5.4, 23.1; P < 0.0001), respectively, for subjects with infection before age 5 versus at ≥10 years; the association was stronger in females than males. Conclusions Earlier Pa infection, particularly before 5 years of age, is strongly associated with severe CF lung disease later in life. This study is not designed to determine causality; Pa infection may be causing lung injury, or may be a marker of ongoing inflammation and lung damage in young children with CF. Pediatr. Pulmonol. 2011; 46:497–504. © 2010 Wiley‐Liss, Inc.